T 0199/20 (ALK-inhibitors/TAKEDA) of 04.11.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T019920.20221104
- Date of decision
- 4 November 2022
- Case number
- T 0199/20
- Online on
- 14 December 2022
- Petition for review of
- -
- Application number
- 09751617.3
- IPC class
- A61K 31/505A61K 31/513
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
- Applicant name
- Takeda Pharmaceutical Company Limited
- Opponent name
- Generics (UK) Ltd
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step (yes)
Inventive step - formulation of the objective technical problem - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
- The decision under appeal is set aside.
- The case is remitted to the opposition division with the order to maintain the patent on the basis of claims 1 to 10 of the main request, filed as auxiliary request 1 with the letter dated 29 October 2018, and, if need be, a description to be adapted thereto.